An analysis of Tuberculosis Treatment Coverage in China indicates a consistent upward trend from 2024 to 2028, with percentages increasing from 93% in 2024 to 96% in 2028. Assuming the actual value in 2023 stood at 92%, this signifies a steady annual improvement. Year-on-year variation: the treatment coverage improves by 1.1% in 2024, with a stable growth pattern thereafter. The Compound Annual Growth Rate (CAGR) for the forecasted period between 2024-2028 reflects an average annual increase of approximately 0.81%.

Future trends to watch for:

Government policies and healthcare funding allocations impacting TB treatment initiatives
Introduction of new TB medications or treatment methodologies
Public health campaigns aimed at early detection and prevention
Technological advancements in diagnostics and patient management systems